We explore how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.
Discover the results of the 2019 Trending Now in Cancer Care Survey—what tops the list of challenges, what areas are trending towards growth, and how cancer programs are evolving to meet the demands of 21st-century cancer care delivery.
When diagnosed with cancer, the typical patient responds
with trepidation, anxiety, and fear. This experience
engenders a bewildering set of questions, including the
cause, treatment options, prognosis, appropriate sources of care,
and affordability. Of paramount importance is ready access to expert
resources with the requisite knowledge and skill. Telemedicine is a
modality of care that addresses all these issues.
In the current oncology clinical trials landscape, many barriers
remain to clinical trial enrollment that affect both the oncologist
and the patient. Among these are trial locations, strict eligibility
requirements, insufficient resources to support appropriate clinical
trial education and screening, as well as patient and provider
attitudes about trials.